nausea and vomiying in cesarean. Vomiting of pregnancy, unspecified
Conditions
Interventions
Intervention 1: Intervention group 2: Midazolam (Tehran Chemie) (2mg) will be prepared in 5 cc syringes and after closing cord randomly injected. Intervention 2: Intervention group 3:Midazolam (2mg) a
Prevention
Intervention group 2: Midazolam (Tehran Chemie) (2mg) will be prepared in 5 cc syringes and after closing cord randomly injected.
Intervention group 3:Midazolam (2mg) and Ondansetron (Tehran Chemie) (4mg) will be prepared in 5 cc syringes and after closing cord randomly injected.
Intervention group 2: Ondansetron (Tehran Chemie) (4mg) will be prepared in 5 cc syringes and after closing cord randomly injected.
Sponsors
Urmia University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Pregnant women aged between 20 and 40 years old; american society of anesthesiologists class 1 and 2; cesarean with spinal anesthesia Exclusion criteria: Patients with a history of gastrointestinal disease; smokers; Motion sickness; Allergies to medicines; Previous history of nausea and vomiting during anesthesia; Preeclampsia, Eclampsia; patients who have used anti-nausea drug in the past 24 hours.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: during and after surgery in recovery. Method of measurement: patient observation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: During operation every 3 minutes after drug injection. Method of measurement: none invasive blood pressure.;Pulse rate. Timepoint: During operation every 3 minutes after drug injection. Method of measurement: Electrocardiogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShahryar Sane
Urmia University of Medical Sciences
Outcome results
None listed